# Focus Universal Inc.: overview FCUV · Nasdaq · CIK 1590418 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/fcuv.md) · [Financials](/companies/fcuv/financials.md) · [Filings](/companies/fcuv/filings.md) · [Insiders](/companies/fcuv/insiders.md) Latest reported revenue: [$675.2k](/filings/0001683168-26-006446.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0001683168-26-006446). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [74.2](/filings/0001683168-25-008135.md) | [133 d](/filings/0001683168-26-002503.md) | [190](/filings/0001683168-26-003903.md) | [35.3](/filings/0001683168-26-006446.md) | [28.7](/filings/0001683168-25-008135.md) | [0.7 d](/filings/0001683168-26-002503.md) | [48.0](/filings/0001683168-26-003903.md) | [675](/filings/0001683168-26-006446.md) | | Gross margin | % | [42.7%](/filings/0001683168-25-008135.md) | [(95.4%) d](/filings/0001683168-26-002503.md) | [16.1%](/filings/0001683168-26-003903.md) | [(35.1%)](/filings/0001683168-25-005910.md) | [(5.6%)](/filings/0001683168-25-008135.md) | [(6912.1%) d](/filings/0001683168-26-002503.md) | [31.8%](/filings/0001683168-26-003903.md) | not reported | | Operating margin | % | [(2353.8%)](/filings/0001683168-25-008135.md) | [(1507.7%) d](/filings/0001683168-26-002503.md) | [(668.3%)](/filings/0001683168-26-003903.md) | [(4366.7%)](/filings/0001683168-26-006446.md) | [(4114.4%)](/filings/0001683168-25-008135.md) | [(119973.6%) d](/filings/0001683168-26-002503.md) | [(2650.9%)](/filings/0001683168-26-003903.md) | [(229.5%)](/filings/0001683168-26-006446.md) | | Net margin | % | [1942.9%](/filings/0001683168-25-008135.md) | [(1472.7%) d](/filings/0001683168-26-002503.md) | [(657.7%)](/filings/0001683168-26-003903.md) | [(4261.7%)](/filings/0001683168-26-006446.md) | [(4065.6%)](/filings/0001683168-25-008135.md) | [(115402.9%) d](/filings/0001683168-26-002503.md) | [(2597.5%)](/filings/0001683168-26-003903.md) | [(225.0%)](/filings/0001683168-26-006446.md) | | Diluted EPS | $ per share | [0.02](/filings/0001683168-24-007704.md) | not reported | [(1.68)](/filings/0001683168-26-003903.md) | not reported | not reported | not reported | [(1.48)](/filings/0001683168-26-003903.md) | not reported | | Free cash flow | $k | [(1,940) d](/filings/0001683168-25-008135.md) | [(1,003) d](/filings/0001683168-26-002503.md) | [(1,243)](/filings/0001683168-26-003903.md) | [(1,430) d](/filings/0001683168-26-006446.md) | [(1,063) d](/filings/0001683168-25-008135.md) | [(1,394) d](/filings/0001683168-26-002503.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [1,434](/filings/0001683168-23-002065.md) | [354](/filings/0001683168-24-001995.md) | [441](/filings/0001683168-25-001278.md) | [398](/filings/0001683168-26-002503.md) | [255](/filings/0001683168-26-002503.md) | | Gross margin | % | [20.7%](/filings/0001683168-23-002065.md) | [6.4%](/filings/0001683168-24-001995.md) | [13.5%](/filings/0001683168-25-001278.md) | [2.6%](/filings/0001683168-26-002503.md) | [(13.8%)](/filings/0001683168-26-002503.md) | | Operating margin | % | [(210.3%)](/filings/0001683168-23-002065.md) | [(1472.1%)](/filings/0001683168-24-001995.md) | [(1124.0%)](/filings/0001683168-25-001278.md) | [(1557.3%)](/filings/0001683168-26-002503.md) | [(1918.8%)](/filings/0001683168-26-002503.md) | | Net margin | % | [(224.5%)](/filings/0001683168-23-002065.md) | [(1393.3%)](/filings/0001683168-24-001995.md) | [(1071.0%)](/filings/0001683168-25-001278.md) | [(803.8%)](/filings/0001683168-26-002503.md) | [(1877.4%)](/filings/0001683168-26-002503.md) | | Diluted EPS | $ per share | [(0.08)](/filings/0001683168-23-002065.md) | [(0.08)](/filings/0001683168-24-001995.md) | [(0.78)](/filings/0001683168-25-001278.md) | [(4.77)](/filings/0001683168-26-002503.md) | [(7.07)](/filings/0001683168-26-002503.md) | | Free cash flow | $k | [(1,992)](/filings/0001683168-23-002065.md) | [(3,000)](/filings/0001683168-24-001995.md) | [(3,549)](/filings/0001683168-25-001278.md) | [(4,675)](/filings/0001683168-26-002503.md) | [(5,131)](/filings/0001683168-26-002503.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fcuv/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $77.0k | 20,269 | | New +20,269 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $43.8k | 11,539 | | New +11,539 | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $3.2k | 843 | | New +843 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.6k | 697 | | New +697 | | [BNP PARIBAS FINANCIAL MARKETS](/funds/1166588.md) | 2026-06-30 | $11 | 3 | | New +3 | | [GROUP ONE TRADING LLC](/funds/932540.md) | 2026-06-30 | $8 | 2 | | New +2 | ## Recent filings [All 282 filings](/companies/fcuv/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-30 | 16:00 ET | [8-K/A](/filings/0001683168-26-008192.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-008192 | | 2026-09-08 | 16:03 ET | [8-K](/filings/0001683168-26-007008.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-007008 | | 2026-08-19 | 16:00 ET | [8-K](/filings/0001683168-26-006590.md) | 5.07 Shareholder vote results | 0001683168-26-006590 | | 2026-08-14 | 13:54 ET | [10-Q](/filings/0001683168-26-006446.md) | Quarterly report, period 2026-06-30 | 0001683168-26-006446 | | 2026-06-25 | 17:21 ET | [8-K](/filings/0001683168-26-005114.md) | 7.01 Regulation FD disclosure | 0001683168-26-005114 | | 2026-06-18 | 11:57 ET | [8-K](/filings/0001683168-26-004961.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001683168-26-004961 | | 2026-05-26 | 15:19 ET | [8-K](/filings/0001683168-26-004299.md) | 8.01 Other events | 0001683168-26-004299 | | 2026-05-14 | 15:16 ET | [10-Q](/filings/0001683168-26-003903.md) | Quarterly report, period 2026-03-31 | 0001683168-26-003903 | | 2026-05-01 | 15:00 ET | [S-1/A](/filings/0001683168-26-003417.md) | Registration statement, amended | 0001683168-26-003417 | | 2026-04-28 | 15:29 ET | [S-1/A](/filings/0001683168-26-003265.md) | Registration statement, amended | 0001683168-26-003265 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001683168-26-002503.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/880b425c-c40d-4a12-83e9-bb91be1518a6) ## About the filer - CIK: 1590418 - Tickers: FCUV - Exchange: Nasdaq - SIC code: 3823 Industrial Instruments For Measurement, Display, and Control - State of incorporation: NV - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:02 ET. No prices; not investment advice.